SpineGuard Releases Its 2025 Financial Calendar Investing.com

PARIS & BOULDER, Colo.–( BUSINESS WIRE )–Regulatory news:

SpineGuard (FR0011464452 “ ALSGD ), an innovative company applying its DSG ® (Dynamic Surgical Guidance) local conductivity sensor technology to secure and simplify the placement of bone implants, today announced its 2025 financial release schedule.

Financial calendar for 2025

Note (): Press releases are published after the stock market closes. This information is subject to change.

About SpineGuard ®

Founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative company that applies its proprietary real-time, radiation-free DSG ® (Dynamic Surgical Guidance) sensor technology to ensure and simplify placing implants in the skeleton. SpineGuard designs, develops and markets medical devices incorporating its technology. Over 100,000 surgical procedures have been performed worldwide thanks to DSG ® , ​​and 34 studies published in peer-reviewed scientific journals have demonstrated the multiple benefits that DSG ® offers to patients, surgeons, surgical staff and hospitals. Building on these strong foundations and several strategic partnerships, SpineGuard expands the scope of its DSG ® technology to the treatment of scoliosis via the anterior approach, sacroiliac joint fusion, dental implantology and innovations such as the «smart» pedicle screw and electric drill or surgical robotics. DSG ® was invented by Maurice Bourlion, Ph.D., Ciaran Bolger, MD, Ph.D., and Alain Vanquaethem, a biomedical engineer. SpineGuard is involved in multiple ESG initiatives.

For additional information, visit www.spineguard.com

Waiver

SpineGuard securities may not be offered or sold in the United States because they have not been and will not be registered under the Securities Act or any state securities laws of the United States, and SpineGuard does not intend to offer its securities publicly in the United States. This is an announcement, not a prospectus, and the information contained herein does not constitute and will not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sale of the securities mentioned herein in the United States in which such offer, solicitation or sale has been would be illegal before registration or exemption from registration.

See the original version on businesswire.com: https://www.businesswire.com/news/home/20250103107539/en/

SpineGuard
Pierre Jérôme
Chief Executive Officer and President
Phone: +33 1 45 18 45 19
p.jerome@spineguard.com

SpineGuard
Anne-Charlotte Millard
financial director
Phone: 01 45 18 45 19
ac.millard@spineguard.com

NewCap
Investor relations and financial communication
Mathilde Bohin / Aurélie Manavarere
Phone: +33 1 44 71 94 94
spineguard@newcap.eu

Source: SpineGuard